Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 28, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022122

« Back to Dashboard
NDA 022122 describes VOLTAREN, which is a drug marketed by Novartis and Glaxosmithkline Cons and is included in four NDAs. It is available from seventeen suppliers. Additional details are available on the VOLTAREN profile page.

The generic ingredient in VOLTAREN is diclofenac sodium. There are forty-seven drug master file entries for this compound. Eighty-one suppliers are listed for this compound. There are five tentative approvals for this compound. Additional details are available on the diclofenac sodium profile page.

Summary for NDA: 022122

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Dermatological Agents
Ophthalmic Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 022122

Suppliers and Packaging for NDA: 022122

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VOLTAREN
diclofenac sodium
GEL;TOPICAL 022122 NDA Alvix Laboratories, LLC 15455-9557 15455-9557-1 1 KIT in 1 CARTON (15455-9557-1) * 100 g in 1 TUBE
VOLTAREN
diclofenac sodium
GEL;TOPICAL 022122 NDA Alvix Laboratories, LLC 15455-9565 15455-9565-1 1 KIT in 1 CARTON (15455-9565-1) * 100 g in 1 TUBE * 3 mL in 1 PATCH

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:GEL;TOPICALStrength1%
Approval Date:Oct 17, 2007TE:ABRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot